rheumatoid arthritis

June 12, 2017August 24, 2022

Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and Drug Administration approving the therapy in May. ... Read more

June 7, 2017June 7, 2017

Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

News, rheumatoid arthritis

Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, according to results of a Phase ... Read more

June 2, 2017June 2, 2017

DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

News, rheumatoid arthritis

Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less cost-effective compared to DMARD combination in ... Read more

May 23, 2017May 23, 2017

Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

News, rheumatoid arthritis

Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid arthritis (RA) who have not responded ... Read more

May 19, 2017May 19, 2017

Potential Treatment Sirukumab Up Before FDA and EMA with High Expectations, J&J Reports

News, rheumatoid arthritis

A potential treatment for moderate-to-severe rheumatoid arthritis, sirukumab, is under consideration by the U.S. Food and Drug Administration for approval, with the application supported by results from five Phase 3 clinical trials. ... Read more

May 12, 2017September 22, 2017

Researchers Uncover Gene Variations Linked to RA, Other Immune Diseases

News, rheumatoid arthritis

A large-scale genetic study, in combination with information from electronic health records (EHRs), identified new human leukocyte antigen (HLA) associations with several immune conditions, including rheumatoid arthritis and multiple sclerosis. ... Read more

May 10, 2017May 10, 2017

Phase 3 Trial Finds Kevzara Superior to Humira, and Just as Safe, in Treating Rheumatoid Arthritis

News, rheumatoid arthritis

The drug Kevzara (sarilumab) is more effective than Humira (adalimumab) — and just as safe — in treating rheumatoid arthritis (RA) in patients who cannot tolerate or don’t respond to ... Read more

May 5, 2017May 5, 2017

Kevzara Takes Step Toward EU Approval, While FDA Decision Is Expected in May

News, rheumatoid arthritis

Kevzara (sarilumab) has received a thumbs-up from the European Medicine Agency (EMA), which has recommended that the European Commission approve it to treat adults with moderate to severe rheumatoid arthritis, according ... Read more

May 3, 2017May 3, 2017

Rheumatoid Arthritis Patients More Likely to Develop Atherosclerosis, British Study Shows

News, rheumatoid arthritis

People with rheumatoid arthritis (RA) are more likely to develop atherosclerosis, a chronic inflammatory condition affecting the heart, according to new research. The study, “Imaging atherosclerosis in rheumatoid arthritis: evidence for ... Read more

April 26, 2017April 26, 2017

Researchers Find 2 Potential Molecules for Fighting Rheumatoid Arthritis, Other Inflammatory Diseases

News, rheumatoid arthritis

Greek researchers have found two molecules — T23 and T8 — that show promise in treating rheumatoid arthritis and other chronic inflammatory diseases. Both molecules act against tumor necrosis factor ... Read more